Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3283998740;98741;98742 chr2:178539550;178539549;178539548chr2:179404277;179404276;179404275
N2AB3119893817;93818;93819 chr2:178539550;178539549;178539548chr2:179404277;179404276;179404275
N2A3027191036;91037;91038 chr2:178539550;178539549;178539548chr2:179404277;179404276;179404275
N2B2377471545;71546;71547 chr2:178539550;178539549;178539548chr2:179404277;179404276;179404275
Novex-12389971920;71921;71922 chr2:178539550;178539549;178539548chr2:179404277;179404276;179404275
Novex-22396672121;72122;72123 chr2:178539550;178539549;178539548chr2:179404277;179404276;179404275
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: P
  • RefSeq wild type transcript codon: CCT
  • RefSeq wild type template codon: GGA
  • Domain: Fn3-127
  • Domain position: 45
  • Structural Position: 54
  • Q(SASA): 0.4672
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
P/R None None 0.83 N 0.665 0.368 0.286081765059 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0
P/T rs949917519 None 0.709 N 0.547 0.219 0.221734844693 gnomAD-4.0.0 2.25781E-05 None None None None N None 0 0 None 0 0 None 0 0 2.69838E-05 0 4.96952E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
P/A 0.1373 likely_benign 0.1261 benign -0.502 Destabilizing 0.41 N 0.443 neutral N 0.431675389 None None N
P/C 0.674 likely_pathogenic 0.6058 pathogenic -0.844 Destabilizing 0.98 D 0.697 prob.neutral None None None None N
P/D 0.5327 ambiguous 0.4609 ambiguous -0.651 Destabilizing 0.764 D 0.576 neutral None None None None N
P/E 0.3909 ambiguous 0.3375 benign -0.76 Destabilizing 0.764 D 0.575 neutral None None None None N
P/F 0.7727 likely_pathogenic 0.6764 pathogenic -0.752 Destabilizing 0.98 D 0.701 prob.neutral None None None None N
P/G 0.287 likely_benign 0.2438 benign -0.599 Destabilizing 0.48 N 0.529 neutral None None None None N
P/H 0.3543 ambiguous 0.2902 benign -0.065 Destabilizing 0.974 D 0.659 neutral N 0.449165071 None None N
P/I 0.6716 likely_pathogenic 0.5751 pathogenic -0.387 Destabilizing 0.866 D 0.705 prob.neutral None None None None N
P/K 0.4572 ambiguous 0.4251 ambiguous -0.612 Destabilizing 0.764 D 0.571 neutral None None None None N
P/L 0.282 likely_benign 0.2347 benign -0.387 Destabilizing 0.83 D 0.68 prob.neutral N 0.447895635 None None N
P/M 0.5762 likely_pathogenic 0.489 ambiguous -0.616 Destabilizing 0.993 D 0.659 neutral None None None None N
P/N 0.4038 ambiguous 0.3216 benign -0.441 Destabilizing 0.764 D 0.641 neutral None None None None N
P/Q 0.2549 likely_benign 0.2263 benign -0.681 Destabilizing 0.866 D 0.611 neutral None None None None N
P/R 0.323 likely_benign 0.2968 benign -0.05 Destabilizing 0.83 D 0.665 neutral N 0.435619771 None None N
P/S 0.1691 likely_benign 0.1478 benign -0.728 Destabilizing 0.01 N 0.351 neutral N 0.361524657 None None N
P/T 0.1808 likely_benign 0.1517 benign -0.746 Destabilizing 0.709 D 0.547 neutral N 0.411473475 None None N
P/V 0.4827 ambiguous 0.3921 ambiguous -0.394 Destabilizing 0.866 D 0.647 neutral None None None None N
P/W 0.8237 likely_pathogenic 0.7502 pathogenic -0.809 Destabilizing 0.993 D 0.719 prob.delet. None None None None N
P/Y 0.6806 likely_pathogenic 0.5767 pathogenic -0.544 Destabilizing 0.98 D 0.701 prob.neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.